Response to "Reconsidering the Classification of YTHDF2 in Glioblastoma” [Response to Letter]

Chenyu Li,1,2 Wei Xie11Shanghai Key Laboratory of Molecular Imaging & Digital and Intelligent Empowerment Biomedical Innovation Center, Pudong Gongli Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, People’s Republic of China; 2GCP Office, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, People’s Republic of ChinaCorrespondence: Wei Xie, Shanghai Key Laboratory of Molecular Imaging & Digital and Intelligent Empowerment Biomedical Innovation Center, Pudong Gongli Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, People’s Republic of China, Email xiew@sumhs.edu.cn